The coronavirus vaccine also halves the risk of Long Covid- breaking latest news

Adults who have completed the anti-Covid vaccination cycle are not only protected from serious disease but have a halved risk of encountering long Covid, in the event of a possible new infection. Many people who become sick with Covid recover within four weeks, but some experience symptoms that persist for weeks and months after the initial infection, making returning to normal life very long and complicated. And this can happen even after people experience mild symptoms of the coronavirus.

The results

Now a new analysis published in The Lancet Infectious Disease based on data collected by the ZOE Covid study, a leading UK surveillance study, has shown that the risk of hospitalization was reduced by about 70%, while the danger of contracting a serious illness (5 or more symptoms in the first week) appeared about a third lower. In the end after two doses of the vaccine, the chances of long Covid decreased by 50%. The researchers analyzed data from the Zoe App from December 8 to July 4, 2021.The authors calculate that, of more than 1.2 million adults who received at least one dose of Pfizer / BioNTech, Oxford-AstraZeneca or Moderna vaccines , less than 0.5% are infected after the first dose and less than 0.2% after the second dose. Among the latter, only 5% reported suffering from long Covid (after-effects of the infection lasting at least 28 days after the positive swab) while among the unvaccinated this percentage rose to 11%. Furthermore, among the recontagated, scientists say, the odds are that there is new infection was asymptomatic they were 63% higher after the first vaccine dose and 94% higher after the second.

Who risks more

The study also indicates that frail over 60s are at greater risk of post-vaccine pandemic coronavirus reinfection, with pre-existing diseases (obesity, heart disease, kidney or lung diseases) or residing in disadvantaged areas such as densely populated urban contexts, especially after a single injection. In particular, in the most vulnerable over 60s compared to healthy ones, the chances of a revolutionary infection after a dose of vaccine were almost doubled. We are at a critical point in the pandemic, as we see cases on the rise around the world due to the Delta variant of Sars-CoV-2, he comments. Claire Steves, at the head of the research. Breakthrough infections are expected, but this doesn’t erase the fact that these vaccines are doing exactly what they were designed for: saving lives and preventing serious disease. Our findings highlight the crucial role vaccines play in broader efforts to prevent infections, which should however include other personal protective measures such as the use of masks, frequent testing and distancing.